These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1415 related articles for article (PubMed ID: 29610508)

  • 1. ACG Clinical Guideline: Management of Crohn's Disease in Adults.
    Lichtenstein GR; Loftus EV; Isaacs KL; Regueiro MD; Gerson LB; Sands BE
    Am J Gastroenterol; 2018 Apr; 113(4):481-517. PubMed ID: 29610508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Crohn's disease in adults.
    Hanauer SB; Meyers S
    Am J Gastroenterol; 1997 Apr; 92(4):559-66. PubMed ID: 9128300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Crohn's disease in adults.
    Lichtenstein GR; Hanauer SB; Sandborn WJ;
    Am J Gastroenterol; 2009 Feb; 104(2):465-83; quiz 464, 484. PubMed ID: 19174807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Anti-Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease.
    Shivashankar R; Pardi DS
    Gastroenterol Clin North Am; 2017 Sep; 46(3):589-601. PubMed ID: 28838417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.
    Grace ND
    Am J Gastroenterol; 1997 Jul; 92(7):1081-91. PubMed ID: 9219775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing biological therapy in Crohn's disease.
    Gecse KB; Végh Z; Lakatos PL
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):37-45. PubMed ID: 26471077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising monitoring in the management of Crohn's disease: a physician's perspective.
    Papay P; Ignjatovic A; Karmiris K; Amarante H; Milheller P; Feagan B; D'Haens G; Marteau P; Reinisch W; Sturm A; Steinwurz F; Egan L; Panés J; Louis E; Colombel JF; Panaccione R
    J Crohns Colitis; 2013 Sep; 7(8):653-69. PubMed ID: 23562672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing anti-TNF treatment in inflammatory bowel disease.
    Rutgeerts P; Van Assche G; Vermeire S
    Gastroenterology; 2004 May; 126(6):1593-610. PubMed ID: 15168370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
    Brookes MJ; Green JR
    Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors.
    Prescrire Int; 2009 Jun; 18(101):108-10. PubMed ID: 19637418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing perianal Crohn's fistula in the anti-TNFα era.
    Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
    Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?
    Subramanian S; Ekbom A; Rhodes JM
    Gut; 2017 Feb; 66(2):362-381. PubMed ID: 27802156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology.
    DuPont HL
    Am J Gastroenterol; 1997 Nov; 92(11):1962-75. PubMed ID: 9362174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice guidelines in acute pancreatitis.
    Banks PA
    Am J Gastroenterol; 1997 Mar; 92(3):377-86. PubMed ID: 9068455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACG Clinical Guideline: Ulcerative Colitis in Adults.
    Rubin DT; Ananthakrishnan AN; Siegel CA; Sauer BG; Long MD
    Am J Gastroenterol; 2019 Mar; 114(3):384-413. PubMed ID: 30840605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.
    Fekety R
    Am J Gastroenterol; 1997 May; 92(5):739-50. PubMed ID: 9149180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience With Anti-TNF-α Biologic Agents in Succession in Patients With Crohn's Disease: A Retrospective Analysis of a Single Center.
    Ferges W; Rampertab SD; Shafqet M; Salimi Q; You G; Yousefzadeh E; Cheng JQ; Das KM
    J Clin Gastroenterol; 2016 Apr; 50(4):326-30. PubMed ID: 25984976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab in fistulizing Crohn's disease.
    Osterman MT; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.